Skip to content
OmniaBio Full Color Logo

Learn more about our CDMO facilities

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
  • Contact
OmniaBio Full Color Logo

Learn more about our CDMO facilities

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
  • Contact

Cell Therapy GMP Manufacturing

At OmniaBio, we are manufacturing a disease-free future through our relentless focus and deep expertise in cell therapy manufacturing.

Facilities and Experts to Meet Your Timeline

We are the experts in lentiviral, genetically modified cells, and iPSC-based development through GMP manufacturing. Leveraging the established foundation and infrastructure of CCRM, we combine our deep expertise with cutting-edge technologies to facilitate the translation of novel cell- and gene-based therapeutics. Our capabilities range from early preclinical development and process development through to commercial-stage GMP manufacturing. Our collaborative and transparent approach to project management, combined with the seamless integration with analytical and regulatory support and phase-appropriate Quality Assurance, ensures your cell or gene therapy asset’s progression to the next developmental milestone.

Dependable and Consistent

We provide best-in-class services and comprehensive phase-specific consultation to support your cell and gene therapy development and manufacturing. When you partner with OmniaBio, you can access deep expertise to facilitate preclinical development, such as GMP iPSC reprogramming, gene editing and differentiation, through custom and high-throughput media development and process development to automate, close and maximize process performance. With the seamless integration of analytical and regulatory support, you can depend on us to consistently deliver as you scale up and scale out.

Let’s Make Medicine
GMP Manufacturing team image

Capacity and Track Record

At OmniaBio, we possess the talent and state-of-the-art manufacturing facilities to ensure we deliver on time and on target.

Let’s Make Medicine
GMP Manufacturing Capacity Image of 2 scientists

Featured Webinar

CAR-T Manufacturing Intensification: The Next Wave of CAR-T Commercialization

Learn from CAR-T industry and healthcare sector experts as they explore the critical intersection of CAR-T cell therapy commercialization strategies and manufacturing technology.

Watch the Webinar

Manufacturing for Your CGT Needs

Immunotherapy

Immunotherapy Icon

Best-in-class solutions for cell therapy development and manufacturing

Learn more about Immunotherapy

Lentiviral Vectors

Lentiviral Vectors Icon

Enhancing gene delivery through end-to-end developmental support

Learn more about
Lentiviral Vectors

iPSC

iPSC Icon

Industry-leading experience and capabilities in stem cell based therapies

Learn more
about iPSC

Contact Us

Let’s Talk About How We Can Help
OmniaBio Footer Logo in Full Color

© 2025 OmniaBio   |   Privacy Policy

  • Expertise
    • Cell & Gene Therapy Expertise
    • Immunotherapy
    • LVV
    • iPSC
  • Services
    • Cell & Gene Therapy Services Overview
    • Process Development
    • Analytical Development
    • Commercial Manufacturing
    • GMP Manufacturing
    • Autologous Cell Therapy Manufacturing
    • Cell Banking
    • Regulatory Guidance
    • Supply Chain Security
  • About
    • Overview
    • Facilities
    • Leadership
    • Careers
  • Resource Centre
    • Posters
    • Blog
    • Webinars
    • Videos
  • Media & Events
    • Press Releases
    • OmniaBio in the News
    • Events
Contact Us
Scroll to Top